National Cancer Institute
National Institutes of Healthwww.cancer.gov
Center for Cancer Research
CCR Home | About CCR | CCR Intranet

Tissue Array Research Program (TARP)

Tissue by X coordinate



Number Sample # Block Code X Coord Y Coord Tumor Type Sex Age Limitations Other Information
501 1 marker core 0 0 Liver        
451 1 normal tissue 1 1 adrenal       XX-00-21A
456 6 normal tissue 1 2 breast       XX-00-35
461 11 normal tissue 1 3 cerebellum       XX-00-17-1A
466 16 normal tissue 1 4 esophagus       XX-00-24E
471 21 normal tissue 1 5 liver       L
476 26 normal tissue 1 7 lymph node        
481 31 normal tissue 1 8 ovary        
486 36 normal tissue 1 9 prostate        
491 41 normal tissue 1 10 small bowel        
496 46 normal tissue 1 11 testis        
26 1 YY-00-0054 1 14 Breast Adenocarcinoma F 67 limited ductal
31 6 YY-00-0060 1 15 Breast Adenocarcinoma F 37 limited poorly differentiated
36 11 YY-00-0066 1 16 Breast Adenocarcinoma F 62   poorly differentiated
41 16 YY-00-0178 1 17 Breast Adenocarcinoma F 34   ductal
46 21 YY-00-0183 1 18 Breast Adenocarcinoma F 70   ductal
51 26 YY-00-0191 1 20 Breast Adenocarcinoma F 43 limited ductal
56 31 YY-00-0199 1 21 Breast Adenocarcinoma F 62   ductal
61 36 YY-00-0210 1 22 Breast Adenocarcinoma F 59   ductal
66 41 YY-00-0215 1 23 Breast Adenocarcinoma F 49 limited ductal, IPOX ER, PR positive
71 46 YY-00-0332 1 24 Breast Adenocarcinoma F U   poorly differentiated
76 51 YY-00-0343 1 26 Breast Adenocarcinoma F U   ductal
81 56 YY-00-0352 1 27 Breast Adenocarcinoma F U   ductal
86 61 YY-00-0359 1 28 Breast Adenocarcinoma F 67   ductal
91 66 YY-01-0004 1 29 Breast Adenocarcinoma F 85 limited ductal
96 71 YY-01-0009 1 30 Breast Adenocarcinoma F 56   ductal, met to LN
452 2 normal tissue 2 1 adrenal      
457 7 normal tissue 2 2 breast        
462 12 normal tissue 2 3 cerebrum, gray matter       XX-00-17-2A
467 17 normal tissue 2 4 esophagus      
472 22 normal tissue 2 5 liver        
477 27 normal tissue 2 7 lymph node        
482 32 normal tissue 2 8 ovary        
487 37 normal tissue 2 9 prostate        
492 42 normal tissue 2 10 small bowel        
497 47 normal tissue 2 11 thyroid        
27 2 YY-00-0055 2 14 Breast Adenocarcinoma F 79   ductal
32 7 YY-00-0062 2 15 Breast Adenocarcinoma F 43 limited ductal, with DCIS present
37 12 YY-00-0069 2 16 Breast Adenocarcinoma F 76   ductal
42 17 YY-00-0179 2 17 Breast Adenocarcinoma F 37   DCIS only
47 22 YY-00-0184 2 18 Breast Adenocarcinoma M 71 limited ductal
52 27 YY-00-0192 2 20 Breast Adenocarcinoma F 53   ductal
57 32 YY-00-0203 2 21 Breast Adenocarcinoma F 74 limited ductal
62 37 YY-00-0211 2 22 Breast Adenocarcinoma F 56   ductal
67 42 YY-00-0216 2 23 Breast Adenocarcinoma F 61 limited ductal IPOX ER positive, PR negative, c-erb-B2 3+
72 47 YY-00-0333 2 24 Breast Adenocarcinoma F 36 limited ductal
77 52 YY-00-0346 2 26 Breast Adenocarcinoma F U   ductal
82 57 YY-00-0353 2 27 Breast Adenocarcinoma F U   ductal
87 62 YY-00-0361 2 28 Breast Adenocarcinoma F U   lobular
92 67 YY-01-0005 2 29 Breast Adenocarcinoma F 36   ductal, met to LN, ER and PR+, c-erb-B2 3+
97 72 YY-01-0011 2 30 Breast Adenocarcinoma F 74   ductal, ER and PR +, cerb-B2 2+
453 3 normal tissue 3 1 bladder       XX-00-19A
458 8 normal tissue 3 2 breast        
463 13 normal tissue 3 3 cerebrum, white matter       XX-00-17-3A
468 18 normal tissue 3 4 heart       XX-00-25A
473 23 normal tissue 3 5 lung       XX-00-7
478 28 normal tissue 3 7 mesothelium        
483 33 normal tissue 3 8 pancreas        
488 38 normal tissue 3 9 salivary gland        
493 43 normal tissue 3 10 spleen        
498 48 normal tissue 3 11 tongue        
28 3 YY-00-0056 3 14 Breast Adenocarcinoma F 49   lobular with signet ring features
33 8 YY-00-0063 3 15 Breast Adenocarcinoma F 48   ductal
38 13 YY-00-0175 3 16 Breast Adenocarcinoma F 40   ductal
43 18 YY-00-0180 3 17 Breast Adenocarcinoma F 27   ductal
48 23 YY-00-0186 3 18 Breast Adenocarcinoma F 45   ductal
53 28 YY-00-0193 3 20 Breast Adenocarcinoma F 68   ductal
58 33 YY-00-0205 3 21 Breast Adenocarcinoma F 67 limited ductal
63 38 YY-00-0212 3 22 Breast Adenocarcinoma F 71   ductal
68 43 YY-00-0218 3 23 Breast Adenocarcinoma F 57   ductal IPOX positive for ER, PR (focal)
73 48 YY-00-0337 3 24 Breast Adenocarcinoma F 75   ductal IPOX positive ER (15%), negative PR, c-erb-B2
78 53 YY-00-0348 3 26 Breast Adenocarcinoma F U   ductal
83 58 YY-00-0354 3 27 Breast Adenocarcinoma F U   lobular with signet rings
88 63 YY-00-0463 3 28 Breast Adenocarcinoma F 56   ductal
93 68 YY-01-0006 3 29 Breast Adenocarcinoma F 51   ductal, ER and PR negative, c-erb-B2 3+
98 73 YY-01-0012 3 30 Breast Adenocarcinoma F 48 limited with in situ, ER and PR+, c-erbB-2 3+
454 4 normal tissue 4 1 bladder        
459 9 normal tissue 4 2 breast        
464 14 normal tissue 4 3 colon       XX-00-10B
469 19 normal tissue 4 4 kidney, cortex       XX-00-9A
474 24 normal tissue 4 5 lung        
479 29 normal tissue 4 7 mesothelium        
484 34 normal tissue 4 8 peripheral nerve        
489 39 normal tissue 4 9 skin        
494 44 normal tissue 4 10 spleen        
499 49 normal tissue 4 11 uterus, endometrium        
29 4 YY-00-0057 4 14 Breast Adenocarcinoma F 70 limited ductal
34 9 YY-00-0064 4 15 Breast Adenocarcinoma F 60   ductal
39 14 YY-00-0176 4 16 Breast Adenocarcinoma F 74 limited ductal
44 19 YY-00-0181 4 17 Breast Adenocarcinoma F 35   ductal
49 24 YY-00-0188 4 18 Breast Adenocarcinoma F 69   ductal, IPOX ER, PR negative
54 29 YY-00-0196 4 20 Breast Adenocarcinoma F 48   ductal
59 34 YY-00-0208 4 21 Breast Adenocarcinoma F 53 limited lobular
64 39 YY-00-0213 4 22 Breast Adenocarcinoma F 57 limited ductal
69 44 YY-00-0219 4 23 Breast Adenocarcinoma F 70   lobular
74 49 YY-00-0339 4 24 Breast Adenocarcinoma F 72 limited ductal
79 54 YY-00-0349 4 26 Breast Adenocarcinoma F U   ductal
84 59 YY-00-0355 4 27 Breast Adenocarcinoma F U   lobular with signet rings
89 64 YY-00-0468 4 28 Breast Adenocarcinoma F 60   ductal
94 69 YY-01-0007 4 29 Breast Adenocarcinoma F 39 limited ductal, c-erb-B2 4+
99 74 YY-01-0013 4 30 Breast Adenocarcinoma F 52   ductal, ER, PR and c-erb-B2 negative
455 5 normal tissue 5 1 bone marrow       XX-00-33A
460 10 normal tissue 5 2 breast        
465 15 normal tissue 5 3 colon        
470 20 normal tissue 5 4 kidney, medulla        
475 25 normal tissue 5 5 lung        
480 30 normal tissue 5 7 muscle        
485 35 normal tissue 5 8 placenta, membranes        
490 40 normal tissue 5 9 skin        
495 45 normal tissue 5 10 stomach        
500 50 normal tissue 5 11 uterus, myometrium        
30 5 YY-00-0059 5 14 Breast Adenocarcinoma F 69 limited ductal
35 10 YY-00-0065 5 15 Breast Adenocarcinoma F 69 limited lobular
40 15 YY-00-0177 5 16 Breast Adenocarcinoma F 37   ductal
45 20 YY-00-0182 5 17 Breast Adenocarcinoma F 63 limited ductal, IPOX ER, PR and c-erb-B2 negative
50 25 YY-00-0189 5 18 Breast Adenocarcinoma F 70   ductal
55 30 YY-00-0197 5 20 Breast Adenocarcinoma F 48   lobular
60 35 YY-00-0209 5 21 Breast Adenocarcinoma F 35   ductal, IPOX ER positive, PR negative
65 40 YY-00-0214 5 22 Breast Adenocarcinoma F 45   ductal
70 45 YY-00-0331 5 23 Breast Adenocarcinoma F 59 limited poorly differentiated, IPOX positive ER, PR, negative c-erb-B2
75 50 YY-00-0342 5 24 Breast Adenocarcinoma F U   ductal
80 55 YY-00-0351 5 26 Breast Adenocarcinoma F U   ductal
85 60 YY-00-0356 5 27 Breast Adenocarcinoma F U   ductal
90 65 YY-01-0002 5 28 Breast Adenocarcinoma F 73   ductal, ER and PR +, c-erb-B2 3+
95 70 YY-01-0008 5 29 Breast Adenocarcinoma F 56 limited lobular, ER +, PR -, c-erb_b2 -
100 75 YY-01-0014 5 30 Breast Adenocarcinoma F 61   met to LN, ER, PR and c-erbB2 negative
101 1 YY-00-0027 7 14 Colonic Adenocarcinoma M 85 limited  
106 6 YY-00-0032 7 15 Colonic Adenocarcinoma F 76    
111 11 YY-00-0041 7 16 Colonic Adenocarcinoma M 67    
116 16 YY-00-0223 7 17 Colonic Adenocarcinoma M 37    
121 21 YY-00-0228 7 18 Colonic Adenocarcinoma M 54    
126 26 YY-00-0233 7 20 Colonic Adenocarcinoma F 76   liver metastasis
131 31 YY-00-0238 7 21 Colonic Adenocarcinoma M 72    
136 36 YY-00-0243 7 22 Colonic Adenocarcinoma M 50 limited  
141 41 YY-00-0248 7 23 Colonic Adenocarcinoma F 72    
146 46 YY-00-0262 7 24 Colonic Adenocarcinoma F 75 limited  
151 51 YY-00-0268 7 26 Colonic Adenocarcinoma M 56    
156 56 YY-00-0278 7 27 Colonic Adenocarcinoma M 58    
161 61 YY-00-0479 7 28 Colonic Adenocarcinoma F 47    
166 66 YY-00-0493 7 29 Colonic Adenocarcinoma F 70    
171 71 YY-01-0018 7 30 Colonic Adenocarcinoma M 70    
1 1 YY-00-0540 8 1 Brain Tumor U U   GBM
6 6 YY-00-0545 8 2 Brain Tumor U U   GBM
11 11 YY-00-0550 8 3 Brain Tumor U U   GBM
16 16 YY-00-0555 8 4 Brain Tumor U U   GBM
21 21 YY-00-0560 8 5 Brain Tumor U U   GBM
301 1 YY-00-0022 8 7 Melanoma F 22   IPOX positive for s100, HMB-45
306 6 YY-00-0095 8 8 Melanoma F 73   IPOX positive for S100, HMB45, vimentin, negative for Cytokeratin (unspecified) & CD45
311 11 YY-00-0257 8 9 Melanoma F 44   IPOX positive for S100, HMB45 (focal)
316 16 YY-00-0505 8 10 Melanoma M 60    
321 21 YY-01-0042 8 11 Melanoma M 59 limited extensive necrosis
102 2 YY-00-0028 8 14 Colonic Adenocarcinoma F 52    
107 7 YY-00-0033 8 15 Colonic Adenocarcinoma M 87    
112 12 YY-00-0043 8 16 Colonic Adenocarcinoma M 64 limited  
117 17 YY-00-0224 8 17 Colonic Adenocarcinoma F 61    
122 22 YY-00-0229 8 18 Colonic Adenocarcinoma M 51    
127 27 YY-00-0234 8 20 Colonic Adenocarcinoma M 81    
132 32 YY-00-0239 8 21 Colonic Adenocarcinoma F 61    
137 37 YY-00-0244 8 22 Colonic Adenocarcinoma M 76 limited  
142 42 YY-00-0249 8 23 Colonic Adenocarcinoma M 38    
147 47 YY-00-0263 8 24 Colonic Adenocarcinoma F U limited  
152 52 YY-00-0269 8 26 Colonic Adenocarcinoma U U    
157 57 YY-00-0283 8 27 Colonic Adenocarcinoma M 68    
162 62 YY-00-0480 8 28 Colonic Adenocarcinoma F 52    
167 67 YY-00-0495 8 29 Colonic Adenocarcinoma M 68    
172 72 YY-01-0019 8 30 Colonic Adenocarcinoma F 68 limited  
2 2 YY-00-0541 9 1 Brain Tumor U U   GBM
7 7 YY-00-0546 9 2 Brain Tumor U U   GBM
12 12 YY-00-0551 9 3 Brain Tumor U U   GBM
17 17 YY-00-0556 9 4 Brain Tumor U U   GBM
22 22 YY-00-0561 9 5 Brain Tumor U U   GBM
302 2 YY-00-0023 9 7 Melanoma F 82    
307 7 YY-00-0096 9 8 Melanoma U U    
312 12 YY-00-0258 9 9 Melanoma M 43    
317 17 YY-00-0506 9 10 Melanoma F 71    
322 22 YY-01-0043 9 11 Melanoma M 50    
103 3 YY-00-0029 9 14 Colonic Adenocarcinoma F 49   Tubular Adenoma only
108 8 YY-00-0034 9 15 Colonic Adenocarcinoma F 67    
113 13 YY-00-0220 9 16 Colonic Adenocarcinoma U U   Tubular Adenoma only
118 18 YY-00-0225 9 17 Colonic Adenocarcinoma F 77    
123 23 YY-00-0230 9 18 Colonic Adenocarcinoma M 90    
128 28 YY-00-0235 9 20 Colonic Adenocarcinoma M 73    
133 33 YY-00-0240 9 21 Colonic Adenocarcinoma F 58    
138 38 YY-00-0245 9 22 Colonic Adenocarcinoma F 83    
143 43 YY-00-0251 9 23 Colonic Adenocarcinoma F 71    
148 48 YY-00-0265 9 24 Colonic Adenocarcinoma U U limited  
153 53 YY-00-0273 9 26 Colonic Adenocarcinoma M 64    
158 58 YY-00-0474 9 27 Colonic Adenocarcinoma F 74    
163 63 YY-00-0484 9 28 Colonic Adenocarcinoma U U    
168 68 YY-00-0497 9 29 Colonic Adenocarcinoma M 49    
173 73 YY-01-0020 9 30 Colonic Adenocarcinoma F 73    
3 3 YY-00-0542 10 1 Brain Tumor U U   GBM
8 8 YY-00-0547 10 2 Brain Tumor U U   GBM
13 13 YY-00-0552 10 3 Brain Tumor U U   GBM
18 18 YY-00-0557 10 4 Brain Tumor U U   GBM
23 23 YY-00-0562 10 5 Brain Tumor U U   GBM
303 3 YY-00-0025 10 7 Melanoma M 41   IPOX positive S100, melin (sp?)
308 8 YY-00-0100 10 8 Melanoma F 78   IPOX positive for HMB45, negative for S100
313 13 YY-00-0499 10 9 Melanoma M 61   IPOX positive S100, negative HMB45
318 18 YY-00-0507 10 10 Melanoma F 51    
323 23 YY-01-0101 10 11 Melanoma U U    
104 4 YY-00-0030 10 14 Colonic Adenocarcinoma F 67 limited  
109 9 YY-00-0035 10 15 Colonic Adenocarcinoma F 86 limited  
114 14 YY-00-0221 10 16 Colonic Adenocarcinoma U U    
119 19 YY-00-0226 10 17 Colonic Adenocarcinoma F 86    
124 24 YY-00-0231 10 18 Colonic Adenocarcinoma M 72    
129 29 YY-00-0236 10 20 Colonic Adenocarcinoma F 88    
134 34 YY-00-0241 10 21 Colonic Adenocarcinoma F 55    
139 39 YY-00-0246 10 22 Colonic Adenocarcinoma M 52    
144 44 YY-00-0252 10 23 Colonic Adenocarcinoma F 69    
149 49 YY-00-0266 10 24 Colonic Adenocarcinoma F 44    
154 54 YY-00-0276 10 26 Colonic Adenocarcinoma M 57    
159 59 YY-00-0475 10 27 Colonic Adenocarcinoma M 79    
164 64 YY-00-0490 10 28 Colonic Adenocarcinoma F 68    
169 69 YY-01-0016 10 29 Colonic Adenocarcinoma M 61    
174 74 YY-01-0021 10 30 Colonic Adenocarcinoma F 54    
4 4 YY-00-0543 11 1 Brain Tumor U U   GBM
9 9 YY-00-0548 11 2 Brain Tumor U U   GBM
14 14 YY-00-0553 11 3 Brain Tumor U U limited GBM
19 19 YY-00-0558 11 4 Brain Tumor U U   GBM
24 24 YY-00-0563 11 5 Brain Tumor U U   GBM
304 4 YY-00-0026 11 7 Melanoma F 79   IPOX positive for S100, HMB-45, negative AE1/3, CAM5.2
309 9 YY-00-0101 11 8 Melanoma M 83   IPOX positive for S100, HMB45, negative for cytokeratin (unspecified), CD3, CD20, CD30
314 14 YY-00-0502 11 9 Melanoma F 73    
319 19 YY-00-0508 11 10 Melanoma M 78    
324 24 YY-01-0102 11 11 Melanoma U U    
105 5 YY-00-0031 11 14 Colonic Adenocarcinoma F 90    
110 10 YY-00-0036 11 15 Colonic Adenocarcinoma F 77 limited  
115 15 YY-00-0222 11 16 Colonic Adenocarcinoma M 39    
120 20 YY-00-0227 11 17 Colonic Adenocarcinoma F 41    
125 25 YY-00-0232 11 18 Colonic Adenocarcinoma F 45    
130 30 YY-00-0237 11 20 Colonic Adenocarcinoma M 71    
135 35 YY-00-0242 11 21 Colonic Adenocarcinoma F 78    
140 40 YY-00-0247 11 22 Colonic Adenocarcinoma F 76    
145 45 YY-00-0261 11 23 Colonic Adenocarcinoma M U    
150 50 YY-00-0267 11 24 Colonic Adenocarcinoma F 47 limited  
155 55 YY-00-0277 11 26 Colonic Adenocarcinoma F 51    
160 60 YY-00-0478 11 27 Colonic Adenocarcinoma M 64    
165 65 YY-00-0492 11 28 Colonic Adenocarcinoma M 36    
170 70 YY-01-0017 11 29 Colonic Adenocarcinoma M 53    
175 75 YY-01-0022 11 30 Colonic Adenocarcinoma F 78   mucinous
5 5 YY-00-0544 12 1 Brain Tumor U U   GBM
10 10 YY-00-0549 12 2 Brain Tumor U U   GBM
15 15 YY-00-0554 12 3 Brain Tumor U U   GBM
20 20 YY-00-0559 12 4 Brain Tumor U U   GBM
25 25 YY-00-0564 12 5 Brain Tumor U U   GBM
305 5 YY-00-0094 12 7 Melanoma M 50    
310 10 YY-00-0254 12 8 Melanoma M 50    
315 15 YY-00-0503 12 9 Melanoma M 49  
320 20 YY-01-0041 12 10 Melanoma M 35    
325 25 YY-01-0103 12 11 Melanoma U U   Pos HMB45, S100, Vimentin; Neg LCA, keratin
176 1 YY-00-0070 13 14 Lung Cancer M 61 limited  
181 6 YY-00-0077 13 15 Lung Cancer M 78    
186 11 YY-00-0086 13 16 Lung Cancer U U    
191 16 YY-00-0140 13 17 Lung Cancer F 73    
196 21 YY-00-0145 13 18 Lung Cancer F 54 limited  
201 26 YY-00-0152 13 20 Lung Cancer F 67    
206 31 YY-00-0158 13 21 Lung Cancer F 76    
211 36 YY-00-0163 13 22 Lung Cancer M 75    
216 41 YY-00-0169 13 23 Lung Cancer M 66 limited  
221 46 YY-00-0190 13 24 Lung Cancer F 38    
226 51 YY-00-0312 13 26 Lung Cancer F 66    
231 56 YY-00-0319 13 27 Lung Cancer M 61    
236 61 YY-00-0528 13 28 Lung Cancer M 40    
241 66 YY-00-0534 13 29 Lung Cancer M 75    
246 71 YY-01-0027 13 30 Lung Cancer M 60   adeno, with papillary features, thyroglobulin negative
251 1 YY-00-0011 14 1 Lymphoma M 14   IPOX: L-26 positive
256 6 YY-00-0016 14 2 Lymphoma F 69   Hodgkins Lyphoma IPOX: R-S cells positive Ki-1, Leu-M1
261 11 YY-00-0045 14 3 Lymphoma M 46   IPOX positive for CD20, CD45R, negative CDw75, CD3, CD43, CD45RO
266 16 YY-00-0051 14 4 Lymphoma F 29   IPOX positive for CD20, CD10, CD5 (weak), negative for CD43, CD3, cyclin D1
271 21 YY-00-0128 14 5 Lymphoma F 34   Hodgkins Lymphoma, R-S cells IPOX positive for CD15, CD30, CD20(focal)
276 26 YY-00-0135 14 7 Lymphoma F 39   IPOX positive for CD20, CD30, negative for CD3, CD15, EMA
281 31 YY-00-0298 14 8 Lymphoma F U   IPOX positive for CD20
286 36 YY-00-0303 14 9 Lymphoma F 59    
291 41 YY-01-0038 14 10 Lymphoma F 70   B-cell, CD20, CD79a, CD30 pos, S-100, LeuM1, CD15 neg
296 46 YY-01-0057 14 11 Lymphoma M 69   Large T cell, pos CD45RO, CD30, CD3, neg for CD20, EMA , CD45R
177 2 YY-00-0071 14 14 Lung Cancer F 74    
182 7 YY-00-0078 14 15 Lung Cancer F 84    
187 12 YY-00-0089 14 16 Lung Cancer U U    
192 17 YY-00-0141 14 17 Lung Cancer M 51    
197 22 YY-00-0146 14 18 Lung Cancer F 80    
202 27 YY-00-0153 14 20 Lung Cancer M 51    
207 32 YY-00-0159 14 21 Lung Cancer M 62    
212 37 YY-00-0165 14 22 Lung Cancer M 73    
217 42 YY-00-0170 14 23 Lung Cancer F 59    
222 47 YY-00-0305 14 24 Lung Cancer F 73 limited  
227 52 YY-00-0314 14 26 Lung Cancer U U    
232 57 YY-00-0320 14 27 Lung Cancer M 71    
237 62 YY-00-0529 14 28 Lung Cancer F 37    
242 67 YY-00-0536 14 29 Lung Cancer M 69    
247 72 YY-01-0028 14 30 Lung Cancer M 66   squamous
252 2 YY-00-0012 15 1 Lymphoma M 59   IPOX: positive for CD19, CD20, CD22, CD10, lambda
257 7 YY-00-0017 15 2 Lymphoma M 89   IPOX: positive for T-marker (unspecfied), CD30
262 12 YY-00-0046 15 3 Lymphoma M 40 PTLD, EBV negatve, clonal by PCR, IPOX CD20 positive
267 17 YY-00-0124 15 4 Lymphoma M U   IPOX positive for CD20
272 22 YY-00-0129 15 5 Lymphoma M 75   IPOX positive for CD20, CD23, CD21, negative CD3, CD43
277 27 YY-00-0137 15 7 Lymphoma M 63   Flow positive for CD19, CD20/CD5 (coexpression) and CD23
282 32 YY-00-0299 15 8 Lymphoma M 74    
287 37 YY-00-0304 15 9 Lymphoma M 37   Hodgkins Lymphoma IPOX positive L-26, EMA, negative for LeuM1, CD30
292 42 YY-01-0039 15 10 Lymphoma M 39   spleen, flow CD2, CD3, CD56, CD16 pos, CD7 dim
297 47 YY-01-0058 15 11 Lymphoma U U   HD, NS, RS cells CD30 pos
178 3 YY-00-0072 15 14 Lung Cancer M 63    
183 8 YY-00-0080 15 15 Lung Cancer M 67    
188 13 YY-00-0092 15 16 Lung Cancer F 50    
193 18 YY-00-0142 15 17 Lung Cancer F 73    
198 23 YY-00-0149 15 18 Lung Cancer M 61    
203 28 YY-00-0154 15 20 Lung Cancer M 68 limited  
208 33 YY-00-0160 15 21 Lung Cancer F 71    
213 38 YY-00-0166 15 22 Lung Cancer M 74 limited  
218 43 YY-00-0171 15 23 Lung Cancer M U limited  
223 48 YY-00-0306 15 24 Lung Cancer M 70 limited  
228 53 YY-00-0315 15 26 Lung Cancer M 54    
233 58 YY-00-0322 15 27 Lung Cancer F 80    
238 63 YY-00-0530 15 28 Lung Cancer M 56    
243 68 YY-00-0537 15 29 Lung Cancer F 73    
248 73 YY-01-0029 15 30 Lung Cancer F 58   squamous
253 3 YY-00-0013 16 1 Lymphoma F 79   IPOX: positive for CD19, CD20, lambda
258 8 YY-00-0018 16 2 Lymphoma M 89   IPOX: positive CD4, CD13, CD30, EMA, vimentin, negative for L-26, CD43
263 13 YY-00-0047 16 3 Lymphoma M 71    
268 18 YY-00-0125 16 4 Lymphoma F 79 Spleen, Flow Kappa restricted, B-cell lineage
273 23 YY-00-0131 16 5 Lymphoma M 34 PTLD, s/p transplant (not specified)
278 28 YY-00-0294 16 7 Lymphoma M 54    
283 33 YY-00-0300 16 8 Lymphoma M 51    
288 38 YY-00-0509 16 9 Lymphoma M 54    
293 43 YY-01-0040 16 10 Lymphoma F 68   spleen, flow CD19, CD20, Kappa, surface IgM pos, CD5 dim
298 48 YY-01-0060 16 11 Lymphoma M 6   flow CD45, CD19, CD20, CD22, Kappa
179 4 YY-00-0073 16 14 Lung Cancer F 48    
184 9 YY-00-0081 16 15 Lung Cancer M 75    
189 14 YY-00-0093 16 16 Lung Cancer M 71    
194 19 YY-00-0143 16 17 Lung Cancer M 78    
199 24 YY-00-0150 16 18 Lung Cancer U U    
204 29 YY-00-0155 16 20